Literature DB >> 2725094

Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.

A M Liberati1, S Cinieri, M Fizzotti, M Schippa, S Ascani, V De Angelis, M Senatore, L Palmisano.   

Abstract

Plastic-adherent depleted or not depleted peripheral mononuclear blood cells (PMBC) from healthy donors showed enhanced lytic activity against 51Cr-labelled K562 target cells when exposed to thymostimulin (TS), 1 microgram ml-1, for 3 h, washed and incubated in TS-free medium before testing for natural killer (NK) cytotoxicity. No modification of NK cell activity was seen when effector cells were treated with placebo (splenic extract). The NK boosting activity of TS was lost when effector cells were treated for 3 h immediately before the performance of the cytotoxic test or when this thymic extract was added directly to the mixture of effector and target cells during the lytic phase of 51Cr release assay.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2725094     DOI: 10.1007/bf02985222

Source DB:  PubMed          Journal:  Med Oncol Tumor Pharmacother        ISSN: 0736-0118


  32 in total

1.  Restoration of immunological responses by THF, a thymic hormone, in mice infected with murine cytomegalovirus (MCMV).

Authors:  E Katorza; M Pecht; R N Apte; D Benharroch; Y Burstein; N Trainin; B Rager-Zisman
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

2.  Thymic hormonal activity on human peripheral blood lymphocytes in vitro. II. Enhancement of the production of immune interferon by activated cells.

Authors:  J Shoham; I Eshel; M Aboud; S Salzberg
Journal:  J Immunol       Date:  1980-07       Impact factor: 5.422

3.  Murine NK cell cultures: effects of interleukin-2 and interferon on cell growth and cytotoxic reactivity.

Authors:  K Kuribayashi; S Gillis; D E Kern; C S Henney
Journal:  J Immunol       Date:  1981-06       Impact factor: 5.422

4.  Interleukin-2 augments natural killer cell activity.

Authors:  C S Henney; K Kuribayashi; D E Kern; S Gillis
Journal:  Nature       Date:  1981-05-28       Impact factor: 49.962

5.  Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.

Authors:  M M Zatz; J Oliver; C Samuels; A B Skotnicki; M B Sztein; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

6.  The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease.

Authors:  M F Martelli; A Velardi; P Rambotti; C Cernetti; A Bertotto; F Spinozzi; A M Bracaglia; B Falini; S Davis
Journal:  Cancer       Date:  1982-08-01       Impact factor: 6.860

7.  Regulatory effects of thymus humoral factor on T cell growth factor in aging mice.

Authors:  J Grinblat; K Schauenstein; E Saltz; N Trainin; A Globerson
Journal:  Mech Ageing Dev       Date:  1983 Jul-Aug       Impact factor: 5.432

8.  Restoration of T-cell function and induction of antitumor immune response in T-cell-depressed spontaneously hypertensive rats by treatment with thymosin fraction 5.

Authors:  N Takeichi; Y Koga; T Fujii; H Kobayashi
Journal:  Cancer Res       Date:  1985-02       Impact factor: 12.701

9.  Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production.

Authors:  M M Zatz; J Oliver; M B Sztein; A B Skotnicki; A L Goldstein
Journal:  J Biol Response Mod       Date:  1985-08

10.  Studies of thymopoietin pentapeptide (TP5) on experimental tumors. I. TP5 relieves immunosuppression in tumor-bearing mice.

Authors:  C Y Lau; E Y Wang; G Goldstein
Journal:  Cell Immunol       Date:  1982-01-15       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.